Brief: Orexo To Launch Second Pharma Product In U.S Late 2024 Or Early 2025

Orexo AB

02/11/2023 10:03

Nov 2 (Reuters) - Orexo AB  ORX.ST :
    * OREXO Q3 2023 INTERIM REPORT
    * WITH APPROVAL, WE WILL LAUNCH OUR SECOND PHARMACEUTICAL
PRODUCT
IN US LATE 2024 OR EARLY 2025
    * REITERATE OUR GUIDANCE TO REACH EBITDA IN -BALANCE FOR H2
2023,
DESPITE EBITDA FOR Q3 COMING IN AT SEK -10 MILLION
    * NEGATIVE RESULT IS EXPLAINED BY SEK 18 MILLION FEE PAID TO
FDA
FOR FILING OF OX124
    * WE -CONTINUE TO REDUCE EXPENSES

Source text: 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))